APRENasdaqPharmaceutical PreparationsFiscal year ends December 31
Aprea Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.53−0.05 (-8.88%)
Close on Oct 19, 2026
- Market cap
- $28.47M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Aprea Therapeutics has not reported a dividend
No dividend per share appears in Aprea Therapeutics's annual filings since fiscal 2016.